| Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829) |
|---|
| 10/14/2004 | WO2004087964A1 Method of detecting detecting mutations |
| 10/14/2004 | WO2004047623A3 Methods for identifying risk of breast cancer and treatments thereof |
| 10/14/2004 | WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 10/14/2004 | US20040202662 Humanised antibodies |
| 10/13/2004 | EP1466012A2 Nucleotide polymorphisms associated with osteoporosis |
| 10/07/2004 | WO2004085670A2 Polarization detection |
| 10/07/2004 | WO2004085666A2 Secreted proteins |
| 10/07/2004 | WO2004067761A3 Method for screening compounds using consensus selection |
| 10/07/2004 | WO2004065619A3 Devices and methods for focusing analytes in an electric field gradient ii |
| 10/07/2004 | WO2004048600A3 Diagnostic tests and methods for diagnosing inflammatory bowel disease |
| 10/07/2004 | US20040197905 Methods and devices for monitoring cellular metabolism in microfluidic cell-retaining chambers |
| 10/07/2004 | US20040197804 Method for in vitro selection of 2'-substituted nucleic acids |
| 10/07/2004 | US20040197801 Nucleic acid sequence detection |
| 10/06/2004 | EP1464705A1 Optimizing cells for endogenous gene activation |
| 10/06/2004 | EP1463838A1 Stain-directed molecular analysis for cancer prognosis and diagnosis |
| 10/06/2004 | EP1463833A1 Light-directed molecular analysis for cancer prognosis and diagnosis |
| 10/06/2004 | EP1463521A2 Gp41 inhibitor |
| 09/30/2004 | WO2004083450A2 Hyperbranched dendron and methods of synthesis and use thereof |
| 09/30/2004 | WO2004083449A2 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 09/30/2004 | WO2004083448A2 Molecular differences between species of the m.tuberculosis complex |
| 09/30/2004 | WO2004083447A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 09/30/2004 | WO2004065615A3 Reversible crosslinking method for making an electro-optic polymer |
| 09/30/2004 | US20040191822 Using restriction fragment length polymorphisms in cytochrome genes to screen for multidrug resistance; tools for monitoring allelic variation generated via exposue to fexofenadine and cyclosporine |
| 09/30/2004 | US20040191812 Target-dependent transcription using deletion mutants of N4 RNA polymerase |
| 09/29/2004 | EP1461464A1 A method for identifying markers |
| 09/23/2004 | WO2004081224A2 Reca-assisted allele specific oligonucleotide extension method |
| 09/23/2004 | WO2004081222A2 Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same |
| 09/23/2004 | WO2004081221A2 Pre-incubation method to improve signal/noise ratio of nucleic acid assays |
| 09/23/2004 | WO2004080271A2 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 09/23/2004 | WO2004055198A3 Device and method for in-line blood testing using biochips |
| 09/23/2004 | US20040187170 Characterisation of gene function using double stranded RNA inhibition |
| 09/23/2004 | US20040185477 uses tagged primer extension in which a set of tag sequences correspond to the identity of the elected target DNA sequence; polymerase chain reaction (PCR); kits |
| 09/23/2004 | US20040185438 for determining a proper course of treatment, irradication, and/or containment of the bioagent in such cases as biological warfare; bioinformatics |
| 09/23/2004 | US20040185437 Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivatives |
| 09/23/2004 | CA2518452A1 Reca-assisted allele specific oligonucleotide extension method for detecting mutations, snps and specific sequences |
| 09/22/2004 | EP1337546A4 Method for detecting hematopoietic stem cells |
| 09/16/2004 | WO2004079011A1 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004078995A2 Methods of modulating and of identifying agents that modulate intracellular calcium |
| 09/16/2004 | WO2004078994A2 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004078992A2 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics |
| 09/16/2004 | WO2004078991A2 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 09/16/2004 | WO2004055199A3 A biological sample storage device and method for biological sample contamination testing |
| 09/16/2004 | WO2004027080A3 Method of extracting nucleic acids from microbial samples |
| 09/16/2004 | US20040181033 Binding agents which inhibit myostatin |
| 09/16/2004 | US20040180401 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 09/16/2004 | US20040180387 Diagnosing ovarian cancer via presence of mesothelin/megakaryocyte potentiating factor polypeptides in urine of women; immunodiagnostics |
| 09/16/2004 | US20040180372 cDNA amplification for expression profiling |
| 09/16/2004 | US20040180345 Using nucleobase interchelating dyes to identify hetroduplex binding in duplex, triplex and quadruplex nucleotide sequence hybridization; polymorphism detection |
| 09/16/2004 | CA2517017A1 Methods for detection of genetic disorders |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/10/2004 | WO2004076684A2 Compositions and methods for the detection of mammalian muscle troponin i |
| 09/10/2004 | WO2004076682A2 Targets for controlling cellular growth and for diagnostic methods |
| 09/10/2004 | WO2004076681A2 System and method for processing identified metabolites |
| 09/10/2004 | WO2004076680A2 Process and composition for inhibiting growth of microorganisms |
| 09/10/2004 | WO2004076677A2 Monoclonal antibody production by ebv transformation of b cells |
| 09/09/2004 | US20040175744 Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers |
| 09/09/2004 | US20040175700 Using phenotypic, genotypic, physiological and morphogenic variation profiles to diagnose and prognose genetic disorders; genomics |
| 09/08/2004 | CN1165629C Electropolymerizable film, and method of making and use thereof |
| 09/02/2004 | WO2004074509A2 Reversible attachment of a membrane active polymer to a polynucleotide |
| 09/02/2004 | WO2004074507A2 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 09/02/2004 | WO2004074506A2 Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers |
| 09/02/2004 | WO2004074505A2 Method for determining functional sites in a protein |
| 09/02/2004 | US20040170958 Viral drug susceptibility testing |
| 09/01/2004 | EP1452608A1 Automated performance of polymerase chain reaction |
| 09/01/2004 | EP1451355A1 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 08/26/2004 | WO2004072297A2 Terminal-phosphate-labeled nucleotides and methods of use |
| 08/26/2004 | WO2004072296A2 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | WO2004072294A2 Methods and means for nucleic acid sequencing |
| 08/26/2004 | WO2004072237A2 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine |
| 08/26/2004 | WO2004072229A2 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/26/2004 | WO2004050897A3 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera |
| 08/26/2004 | WO2004042072A9 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 08/26/2004 | US20040166058 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/26/2004 | CA2515938A1 Methods and means for nucleic acid sequencing |
| 08/26/2004 | CA2515211A1 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine |
| 08/26/2004 | CA2515039A1 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/26/2004 | CA2514955A1 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | CA2513672A1 Terminal-phosphate-labeled nucleotides and methods of use |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780580 Method of screening candidate compounds for susceptibility to biliary excretion |
| 08/19/2004 | WO2004070054A2 Methods for preventing mitochondrial permeability transition |
| 08/19/2004 | WO2004070053A2 cDNA AMPLIFICATION FOR EXPRESSION PROFILING |
| 08/19/2004 | WO2004070051A2 Chemical proteomics |
| 08/19/2004 | US20040163146 Vascular-preferred promoters |
| 08/19/2004 | US20040162712 Method for screening compounds using consensus selection |
| 08/19/2004 | US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample |
| 08/19/2004 | US20040161770 Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| 08/19/2004 | US20040161417 Inhibiting expression of invariant chain protein (li) in antigen presenting cells |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/12/2004 | WO2004067767A1 Method of screening cell death modulators. |
| 08/12/2004 | WO2004067765A2 Organism fingerprinting using nicking agents |
| 08/12/2004 | WO2004067762A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 08/12/2004 | WO2004067761A2 Method for screening compounds using consensus selection |
| 08/12/2004 | WO2004016802A3 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 08/12/2004 | WO2004015133A3 Combinatorial synthesis system |
| 08/12/2004 | US20040157243 Amplifying nucleic acid from sample, hybridizing with probe designed to detect presence different sequences; used to diagnose cancer and diseases associated with chromosomal anomalies |
| 08/12/2004 | US20040157223 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/12/2004 | US20040157219 comprises an alkaline agent, at least one detergent, and a suspension of paramagnetic particles and an acidic solution |
| 08/11/2004 | EP1444525A2 Bag-1 mediated down-regulation of glucocorticoid-receptor transactivation |
| 08/05/2004 | WO2004065619A2 Devices and methods for focusing analytes in an electric field gradient ii |